DNA demethylation in the PTEN gene promoter induced by 5‑azacytidine activates PTEN expression in the MG‑63 human osteosarcoma cell line

Song,Deye; Ni,Jiangdong; Xie,Hongming; Ding,Muliang; Wang,Jun

doi:10.3892/etm.2014.1571

May-2014 Volume 7 Issue 5

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

May-2014 Volume 7 Issue 5

Full Size Image

Article Open Access

DNA demethylation in the PTEN gene promoter induced by 5‑azacytidine activates PTEN expression in the MG‑63 human osteosarcoma cell line

Authors:
- Deye Song
- Jiangdong Ni
- Hongming Xie
- Muliang Ding
- Jun Wang
View Affiliations / Copyright

Affiliations: Department of Orthopaedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China
Pages: 1071-1076
|
Published online on: February 21, 2014

https://doi.org/10.3892/etm.2014.1571
Expand metrics +

Abstract

This study used the MG‑63 osteosarcoma cell line to investigate the demethylation of the phosphate and tension homolog (PTEN) gene promoter and the change in PTEN gene expression levels, which are caused by the methylation inhibitor 5‑azacytidine (5‑Zac), and the association between the two. Different concentrations of 5‑Zac (0, 5 and 10 µmol/l) were added into the MG‑63 cell culture medium and the cells were cultured for 72 h. The following techniques were performed on the cells: Western blot analysis to detect the PTEN protein; reverse transcription‑polymerase chain reaction (PCR) to detect the mRNA transcription levels of the PTEN gene; flow cytometry to detect the cell apoptotic rate; and sodium bisulfate to deal with the DNA of each group. The genes of the PTEN promoter and the transcription factors specificity protein 1 (Sp1) and Myc were PCR amplified and transformed into Escherichia coli, then a number of clones were selected for sequencing and the methylation status of the amplified PTEN promoter fragment was detected. Following culture of the MG‑63 cells with 5‑Zac at concentrations of 0, 5 and 10 µmol/l for 72 h, the expression levels of PTEN protein in each group were gradually increased, presenting a concentration‑dependent effect: Group 0 µmol/l compared with groups 5 and 10 µmol/l, P<0.05; and group 5 µmol/l compared with group 10 µmol/l, P=0.007. The mRNA expression levels of the PTEN gene significantly increased. The apoptotic rates of groups 0, 5 and 10 µmol/l were 0.69±0.42, 2.50±0.30 and 6.59±0.62%, and significant differences (P<0.01) were observed between every two groups. The bisulfate DNA sequencing results of three groups showed that, following the treatment with 5‑Zac, the binding of the CG site to transcription factors was affected by demethylation. The average rate of demethylation indicated a statistical difference among the three groups. In conclusion, the methylation inhibitor 5‑Zac leads to a significant increase in the expression levels of the tumor suppressor gene PTEN in the MG‑63 osteosarcoma cell line in vitro. The expression levels of mRNA and the cellular apoptotic rate were also increased. The elevated activation and expression levels of the PTEN gene may be associated with the low methylation levels of the CG site that binds to the transcription factors Sp1 and Myc in the PTEN gene promoter, and they promote the combination of the transcription factors and the gene promoter.

View Figures

View References

1	Mirabello L, Troisi RJ and Savage SA: Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
2	Bielack SS and Carrle D: State-of-the-art approach in selective curable tumors: bone sarcoma. Ann Oncol. 19(Suppl 7): vii155–vii160. 2008. View Article : Google Scholar : PubMed/NCBI
3	Picci P, Mercuri M, Ferrari S, et al: Survival in high-grade osteosarcoma: improvement over 21 years at a single institution. Ann Oncol. 21:1366–1373. 2010.PubMed/NCBI
4	Yim EK, Peng G, Dai H, et al: Rak functions as a tumor suppressor by regulating PTEN protein stability and function. Cancer Cell. 15:304–314. 2009. View Article : Google Scholar
5	Song MS, Carracedo A, Salmena L, et al: Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner. Cell. 144:187–199. 2011. View Article : Google Scholar : PubMed/NCBI
6	Li L, Ernsting BR, Wishart MJ, Lohse DL and Dixon JE: A family of putative tumor suppressors is structurally and functionally conserved in humans and yeast. J Biol Chem. 272:29403–29406. 1997. View Article : Google Scholar : PubMed/NCBI
7	Yu J, Zhang SS, Saito K, et al: PTEN regulation by Akt-EGR1-ARF-PTEN axis. EMBO J. 28:21–33. 2009. View Article : Google Scholar : PubMed/NCBI
8	Tamura M, Gu J, Danen EH, et al: PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway. J Biol Chem. 274:20693–20703. 1999. View Article : Google Scholar : PubMed/NCBI
9	Chung JH, Ostrowski MC, Romigh T, et al: The ERK1/2 pathway modulates nuclear PTEN-mediated cell cycle arrest by cyclin D1 transcriptional regulation. Hum Mol Genet. 15:2553–2559. 2006. View Article : Google Scholar : PubMed/NCBI
10	Huang T, Sun J, Lu G, et al: Expression and significance of PTEN in osteosarcoma. J Chin Med Univ. 33:245–246. 2004.
11	Nielsen-Preiss SM, Silva SR and Gillette JM: Role of PTEN and Akt in the regulation of growth and apoptosis in human osteoblastic cells. J Cell Biochem. 90:964–975. 2003. View Article : Google Scholar : PubMed/NCBI
12	Tsumura A, Hayakawa T, Kumaki Y, et al: Maintenance of self-renewal ability of mouse embryonic stem cells in the absence of DNA methyltransferases Dnmtl, Dnmt3a and Dnmt3b. Genes Cells. 11:805–814. 2006. View Article : Google Scholar : PubMed/NCBI
13	Polanowska J, Martin JS, Garcia-Muse T, et al: A conserved pathway to activate BRCA1-dependent ubiquitylation at DNA damage sites. EMBO J. 25:2178–2188. 2006. View Article : Google Scholar : PubMed/NCBI
14	Hashemi M, Rezaei H, Eskandari-Nasab E, Kaykhaei MA and Taheri M: Association of promoter methylation and 32-bp deletion of the PTEN gene with susceptibility to metabolic syndrome. Mol Med Rep. 7:342–346. 2013.PubMed/NCBI
15	Lubecka-Pietruszewska K, Kaufman-Szymczyk A, Stefanska B and Fabianowska-Majewska K: Folic acid enforces DNA methylation-mediated transcriptional silencing of PTEN, APC and RARbeta2 tumour suppressor genes in breast cancer. Biochem Biophys Res Commun. 430:623–628. 2013. View Article : Google Scholar : PubMed/NCBI
16	Bian EB, Huang C, Ma TT, Tao H, Zhang H, Cheng C, Lv XW and Li J: DNMT1-mediated PTEN hypermethylation confers hepatic stellate cell activation and liver fibrogenesis in rats. Toxicol Appl Pharmacol. 264:13–22. 2012. View Article : Google Scholar : PubMed/NCBI
17	Kou XX, Hao T, Meng Z, Zhou YH and Gan YH: Acetylated Sp1 inhibits PTEN expression through binding to PTEN core promoter and recruitment of HDAC1 and promotes cancer cell migration and invasion. Carcinogenesis. 34:58–67. 2013. View Article : Google Scholar : PubMed/NCBI
18	Peyrou M, Bourgoin L and Foti M: PTEN in liver diseases and cancer. World J Gastroenterol. 16:4627–4633. 2010. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

DNA demethylation in the PTEN gene promoter induced by 5‑azacytidine activates PTEN expression in the MG‑63 human osteosarcoma cell line

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Related Articles